Share

April 13, 2021; 96 (15 Supplement) Saturday, April 17

Long-term Effect of Siponimod on MRI Outcomes in SPMS: Analyses from the EXPAND Study up to 5 Years (2217)

Douglas L. Arnold, Ludwig Kappos, Patrick Vermersch, Ralf Gold, Amit Bar-Or, Gavin Giovannoni, Bruce A.C. Cree, Daniela Piani Meier, Shannon Ritter, Goeril Karlsson, Frank Dahlke, Thomas Hach, Robert J. Fox
First published April 13, 2021,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 96 no. 15 Supplement 2217
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 13, 2021.
Copyright & Usage: 
© 2021

Author Disclosures

    1. Douglas L. Arnold1,2,
    2. Ludwig Kappos3,
    3. Patrick Vermersch4,
    4. Ralf Gold5,
    5. Amit Bar-Or6,
    6. Gavin Giovannoni7,
    7. Bruce A.C. Cree8,
    8. Daniela Piani Meier9,
    9. Shannon Ritter10,
    10. Goeril Karlsson9,
    11. Frank Dahlke9,
    12. Thomas Hach9 and
    13. Robert J. Fox11
  1. Douglas L. Arnold1,2,
  2. Ludwig Kappos3,
  3. Patrick Vermersch4,
  4. Ralf Gold5,
  5. Amit Bar-Or6,
  6. Gavin Giovannoni7,
  7. Bruce A.C. Cree8,
  8. Daniela Piani Meier9,
  9. Shannon Ritter10,
  10. Goeril Karlsson9,
  11. Frank Dahlke9,
  12. Thomas Hach9 and
  13. Robert J. Fox11
  1. 1Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
  2. 2NeuroRx Research, Montreal, Quebec, Canada
  3. 3Neurologic Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland
  4. 4Univ. Lille, Inserm UMR U1172 LilNCog, CHU Lille, FHU Imminent, Lille, France
  5. 5Department of Neurology, St Josef-Hospital/Ruhr-University Bochum, Bochum, Germany
  6. 6Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  7. 7Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
  8. 8UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA
  9. 9Novartis Pharma AG, Basel, Switzerland
  10. 10Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
  11. 11Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland, OH, USA

Article usage

Article usage: April 2021 to December 2022

AbstractFullPdfSource
Apr 20212200Highwire
May 20211900Highwire
Jun 20211500Highwire
Jul 20211600Highwire
Aug 20213900Highwire
Sep 20213000Highwire
Oct 20214100Highwire
Nov 20212900Highwire
Dec 20211500Highwire
Jan 20222000Highwire
Feb 20221300Highwire
Mar 20223000Highwire
Apr 20222700Highwire
May 20221800Highwire
Jun 20221200Highwire
Jul 2022800Highwire
Aug 2022500Highwire
Sep 20221100Highwire
Oct 20221300Highwire
Nov 2022800Highwire
Dec 2022400Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me